Genomictree Inc.
228760
Rang in Aktien
#19171
Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to... Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to develop and market advanced detection tools for both oncological conditions and various infectious diseases. Its product line includes EarlyTect C, a screening solution for the early identification of colorectal cancer. For lung cancer, it offers EarlyTect L, which targets epigenetic markers in patients with pulmonary nodules, and for bladder cancer, EarlyTect B, designed to detect specific genetic and epigenetic markers in individuals with hematuria. The company also provides a range of companion diagnostics: AccuraTect-KRAS and AccuraTect-BRAF assist in colorectal cancer management, while AccuraTect-EGFR supports lung cancer treatment. In addition, Genomictree supplies AccuraDTect SARS-CoV-2 RT-qPCR kits for infectious disease testing, and offers its technologies to support various diagnostic test providers. Founded in 2000, the company is based in Daejeon, South Korea.
Aktienkurs
$6.61
Marktkapitalisierung
$162.26M
Veränderung (1 Tag)
1.06%
Veränderung (1 Jahr)
-50.87%
Land
KR
Handel Genomictree Inc. (228760)
Kategorie
Healthcare
Marktkapitalisierung von Genomictree Inc.(228760)
Marktkapitalisierung: $162.26M
Mit Stand October 2026 hat Genomictree Inc. eine Marktkapitalisierung von $162.26M. Das macht Genomictree Inc. laut unseren Daten zum 19171st wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Genomictree Inc. von 2017 bis 2026
228760 im Vergleich zu den Top 5 der beliebtesten stocks
| Preis für 228760 | Vermögenswert B | Marktkapitalisierung von B | Ergebnisse | |
|---|---|---|---|---|
|
$215,477
$162.26M
|
$5.289T | +3,259,431.37% | ||
|
$202,892
$162.26M
|
$4.980T | +3,069,048.93% | ||
|
$170,111
$162.26M
|
$4.175T | +2,573,168.46% | ||
|
$161,426
$162.26M
|
$3.962T | +2,441,797.15% | ||
|
$115,312
$162.26M
|
$2.830T | +1,744,224.92% |